KRAS and neoplasm: More specifically, acinar cells lacking PTF1A are more frequently transformed by KRAS [45,46], while NR5A2 prevents KRAS induced neoplasia through the maintenance of acinar cell plasticity [47], and PDAC metastasis has been observed to increase with the activation of KRAS and the expression of c-Myc TFs [48].